JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Sunlight, iron and radicals to tackle the resistant leftovers of biotreated winery wastewater.

Winery wastewater is characterized by high organic content consisting of alcohols, acids and recalcitrant high-molecular-weight compounds (e.g. polyphenols, tannins and lignins). So far, biological treatment constitutes the best available technology for such effluents that are characterized by high seasonal variability; however the strict legislation applied on the reclamation and reuse of wastewaters for irrigation purposes introduces the need for further treatment of the bioresistant fraction of winery effluents. In this context, the use of alternative treatment technologies, aiming to mineralize or transform refractory molecules into others which could be further biodegraded, is a matter of great concern. In this study, a winery effluent that had already been treated in a sequencing batch reactor was subjected to further purification by homogeneous and heterogeneous solar Fenton oxidation processes. The effect of various operating variables such as catalyst and oxidant concentration, initial pH, temperature and lamp power on the abatement of chemical oxygen demand (COD), dissolved organic carbon (DOC), color, total phenolics and ecotoxicity has been assessed in the homogeneous solar Fenton process. In addition, a comparative assessment between homogeneous and heterogeneous solar Fenton processes was performed. In the present study the homogeneous solar Fenton process has been demonstrated to be the most effective process, yielding COD, DOC and total phenolics removal of about 69%, 48% and 71% in 120 min of the photocatalytic treatment, respectively.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app